Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatmen

Dezawa MuseCells® is a registered trademark, and Muse Cell Innovations® is the exclusive global licensor of this cellular platform.

Only official licensees are granted access to validated protocols, safety data, and platform-level implementation support.

All procedures for sourcing, handling, and verifying Dezawa MuseCells® are proprietary and delivered only to authorized partners.

We make no guarantees regarding the handling, quality, or safety of cells outside of the licensed supply chain. Use of the Dezawa MuseCells® name or likeness without license is prohibited.

Accept no substitutes. Work only with verified licensees.

MENU

Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatmen

LATEST ON DEZAWA MUSE CELLS®

Publications

Macrophage- and pluripotent-like reparative Muse cells are unique endogenous stem cells distinct from other somatic stem cells

Publications

Unique multipotent cells in adult human mesenchymal cell populations

Publications

Nose-to-brain delivery of human muse cells enhances structural and functional recovery in the murine ischemic stroke model

Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatmen

Publications

Macrophage- and pluripotent-like reparative Muse cells are unique endogenous stem cells distinct from other somatic stem cells

Publications

Unique multipotent cells in adult human mesenchymal cell populations

Publications

Nose-to-brain delivery of human muse cells enhances structural and functional recovery in the murine ischemic stroke model

Request Licensing Information